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Abstract Venous blood returning from the splanchnic viscera has liver-supporting 
(hepatotrophic) qualities not found to the same degree in other kinds of arterial 
or venous blood. The effects of portal blood have been noted in animals with two 
livers (or a differential portal blood supply to different regions of one liver) to 
include hypertrophy, glycogen storage, hyperplasia, capacity for regeneration, 
increase of several synthetic functions, and maintenance of normal structure. The 
main splanchnic venous hepatotrophic factors are endogenous hormones of 
which the single most important is insulin. Thus, the foregoing portal hepato-
trophic effects are largely eliminated with the diabetes produced by alloxan or 
total pancreatectomy. 
The injury of portacaval shunt is caused by the diversion of the hormones 
around the liver. Accordingly, the atrophy, injury to the organelles, and loss of 
the capacity for cell renewal is minimized if insulin is infused into the portally 
deprived liver. In these and other experiments, exogenous glucagon alone or the 
addition of glucagon to insulin has had no effect, but this may be because of the 
masking presence of gut glucagon and other hormonal or non-hormonal sub-
stances in our models. 
At present, the effects on the liver of exogenous insulin, glucagon, epidermal 
growth factor, and numerous other hormones are being determined by their in-
traportal infusion into eviscerated dogs in which other endogenous spianchnic 
factors have been eliminated. 
In this paper we shall be summarizing an array of evidence from our centre 
about how hormones released by the splanchnic organs into the portal venous 
system can influence the morphology, regenerative capacity, and function of 
the liver in ways that were not even suspected until quite recently. It may be 
well to state in advance our conclusion that insulin is the most important of 
these portal blood constituents which we have collectively termed portal 
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hepatotrophic substances but in addition to emphasize our belief that many 
other less important factors are also involved. 
Although we shall be focusing for the most part on our own observations, 
we would be remiss Dot to acknowledge the supporting data and/or new in-
formation coming from other laboratories. Recent summaries have been pub-
lished of the important work done with in vivo preparations at Columbia 
University (Price 1976; Whittemore et of. 1975), the University of California, 
San Diego (Broelsch et ai, 1974; Duguay & Orloff 1976), Harvard University 
(Bucher & Swaffield 1975; Farivar et ol. 1976), and the University of Pitts-
burgh (Fisher et of. 1971). Within the past several years, Gerschenson et 01. 
(1972), Benzo & De La Haba (1972), Wagle et al. (1973), Leffert (1974; Leffert 
et al. 1976), and Richman et al. (1976) have used hepatocyte culture prepa-
rations to test the role of insulin and other hormones in controlling the 
growth, replication, and function of liver cells. 
ECK FISTULA 
• 
Much of the evidence supporting the importance of insulin as a hepato-
trophic factor has to do with what happens when the liver is deprived of portal 
venous blood or that portion of portal blood that emanates from the pancreas . 
The most extreme portaprival state is when all the splanchnic venous return 
is diverted around the liver via a portacaval shunt, leaving the liver with only 
an arterial supply. Portacaval shunt is also called Eck's fistula after the Russian 
military surgeon who described it in dogs 100 years ago (Eck 1877). Few 
articles have led to such prolonged controversy as this one. 
On the basis of the short-term survival of one of his eight dogs, Eck thought 
that a completely diverting portacaval shunt was compatible with prolonged 
good health. This conclusion was refuted by Hahn et al. (1893) whose dogs 
with Eck fistula developed weight loss, liver atrophy and hepatic encephalo-
pathy. The inability in ensuing years to explain these consequences caused 
Bollman (1961) of the Mayo Clinic to write: 'In the 83 years since it was first 
reported, the Eck fistula has been reasonably successful in hiding its secrets 
as well as in giving rise to may additional questions fundamental to an under-
standing of the functions of the intestine, liver, and brain'. 
The light microscopic changes in the liver caused by portal blood deprivation 
include atrophy, fatty infiltration, and deglycogenation. Ultrastructurally, the 
most striking and specific changes are depletion and disruption of the rough 
endoplasmic reticulum, and reduction in the membrane-bound ribosomes. 
We now realize that all these events occur with surprising speed, being about 
90 % complete within four days (Starzl et af. 1976). We also know from other 
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work recently summarized by Putnam et af. (l976) that the same general 
light and electron microscopic changes have been seen after portal diversion 
in the livers of rats, dogs, swine, baboons, and humans with some variations 
in degree. Thus, the hepatic injury of Eck fistula is common to all species so 
far studied. The metabolic consequences have been the mildest in rats and man. 
When Bollman (1961) summarized the situation of Eck fistula (quoted 
above), it was widely accepted in what was called the flow hypothesis that the 
Eck fistula syndrome was caused by a suboptimal volume, as opposed to 
quality, of hepatic blood flow. This conclusion had what looked like incon-
trovertible support from the classic paper by Child et af. (195'3) entitled 'Liver 
regeneration following portacaval transposition in dogs'. With portacaval 
transposition the splanchnic venous blood is diverted by an end-to-end anasto-
mosis to the transected upper vena cava but the lost portal blood is replaced 
with an inflow to the hilar portal vein from the transected distal inferior vena 
cava. With this portal blood replacement, Child avoided in dogs most of the 
adverse effects of Eck fistula. Fisher et al. (1954) had similar results using 
arterial blood for portal flow replacement. Thus, portal blood seemed to 
possess no physiologically import~nt special qualities. 
THE UNMASKING ROLE OF AUXILIARY LIVER TRANSPLANTATION 
The flow hypothesis began to fall apart about 13 years ago with experiments 
done in dogs to define the necessary conditions for auxiliary liver transplan-
tation. If an extra canine liver was not given splanchnic blood, it promptly 
underwent severe shrinkage (Starzl et af. 1964) even though the lost portal 
flow was replaced with' equal volumes of systemic blood (Fig. 1). Conversely, 
if the graft was given the splanchnic venous return, the acute atrophy now 
affected the native liver (Marchioro et al. 1965a). The organ with first access 
to the splanchnic venous blood apparently was efficiently extracting something 
(subsequent work has shown this to be mainly insulin; see later), the absence 
of which was profoundly damaging to the second organ. 
PARTIAL (SPLIT) PORTACAVAL TRANSPOSITION 
The transplant preparations which had made apparent the foregoing phys-
iological effect had a flaw which prevented complete acceptance of the he pat-
otrophic concept. There was, in addition to different kinds of portal va~cula­
rization, an inherent inequality of the two organs since the homograft (or 
auxiliary liver) was often under immunological attack despite host immuno-
suppression, whereas the animal's own liver was not. Consequently, we under-
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FIG. 1. An auxiliary homograft (right) and the recipient dog's own liver (left), 45 days 
after transplantation. The graft ponal vein was vascularized with systemic venous return. 
Normal splanchnic inflow was retained for the host liver. (From Starzl et al. 1964, by per-
mission of Annals of Surgery.) 
took other experiments which were designed to eliminate this objection. 
The key step was the introduction of what has been termed a split or partial 
transposition which in effect divided the animal's own liver into two fragments 
(Marchioro et al. 1965b, 1967). With this operation, splanchnic venous blood 
is provided for one portal branch of the liver, whereas the other portal branch 
is detached and supplied with blood from the inferior vena cava (Fig. 2A). 
The quantity of flow was measured in many of these experiments and found 
to be generally greater on the side perfused by vena caval blood. 
The results from this work were clear (Marchioro et af. 1965b, 1967). The 
lobes receiving splanchnic blood always were hypertrophic relative to the 
hepatic lobes nourished by systemic venous inflow. Furthermore, the splanch-
nic-fed lobes always had more hepatocyte mitoses than the liver tissue on the 
other side, indicating an influence of portal blood on cell renewal and 
presumably regeneration. 
The two liver sides after partial transposition have been demonstrated to 
have other easily quantifiable differences using experiments in which the splanch-
nic venous blood went to the right lobes for 60 days (Starzl et al. 1973, 1975a). 
I 
r 
c 
1-
al 
ts 
,d 
~h 
). 
ld 
he 
he 
h-
. he 
nd 
to 
;h-
a). 
HEPATOTROPHIC COSTROVERSY 
Normal 
pancreas 
Split transposition 
Alloxan diabetes 
115 
Pancreatectomy 
FIG. 2. Partial or split portacaval transposition experiments in which the non-hepatic splan-
chnic venous return was directed in its entirety to the right lobes, and the inferior vena caval 
blood was used to perfuse the leCt liver lobes by anastomosing the supra-adrenal inferior vena 
cava to the detached left portal branch. A. Non-diabetic dogs. B. Dogs with alloxan-induced 
diabetes. c. Dogs with total pancreatectomy. (From Starzl et 01. 19750, by permission of 
Surgery, Gynecology & Obstetrics.) 
The splanchnic-fed lobes had more glycogen and glucokinase, lower concen-
trations of cyclic 3' : 5' -adenosine monophosphate (cyclic AMP) and active 
phosphorylase, increased deoxyribonucleic acid (DNA) synthesis and higher 
cholesterol synthesis. The biochemical dissociation was shown in many other 
ways that will not be detailed here. But a reasonable generalization was that 
the two liver sides were living in different metabolic worlds in which hormone 
control, especially that by insulin, played the dominant role . 
The significance of the pancreatic hormones in these differential effects was 
further studied in partial transposition experiments in which some of the dogs 
were made diabetic with alloxan (Fig. 2B) or by total pancreatectomy (Fig_ 2c) 
and then treated with subcutaneous insulin (Starzl et al. 1975a, b). The exogen-
ous insulin now was expected to be distributed without obvious preference 
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FIG. 3. Hepatocyte shadows traced during histopathological examination, cut out on stan-
dard paper and weighed as an index of hepatocyte size. (From Starzl et al. 1973, by permission 
of Surgery, Gynecology & Obstetrics.) 
to both sides. The right lobes were receiving the total splanchnic venous return 
and the left had systemic blood. 
A previously developed and exquisitely accurate way to measure liver cell 
atrophy was exploited for such experiments. With light microscope tracing 
hepatocytes were drawn on a standard thickness paper and weighed (Fig. 3). 
The weights were called size units. These measures correlated well with the 
true size of single cells as measured directly with planimetry and other tech-
niques. The cell size data could then be summarized in graphs. 
In split transposition experiments which ran for 60 days, the hepatocytes 
in the right lobes receiving the total splanchnic venous return of non-diabetic 
dogs were twice as large as their left-sided companions receiving vena cava 
blood. The cell size advantage was lost by the superimposition of alloxan 
diabetes, or of total pancreatectomy (Starzl et al. 1975b). 
In non-diabetic dogs these same right lobes receiving the total splanchnic 
blood also had a higher rate of cell mitosis as measured by autoradiography, 
and the rates on both sides were higher than normal. The right-sided advan-
tage was only partly removed by alldxan and pancreatectomy diabetes (Starzl 
et al. 1975b). These dogs were being treated with subcutaneous insulin which 
was distributed to both sides. We think the residual difference in right and 
left hepatocyte proliferation with retention of some right-sided advantage 
even after diabetes represented an influence on cell renewal of splanchnic fac-
tors other than insulin, a point to which we shall return later. 
Diverse other measures including DNA synthesis, lipid synthesis, and the 
ability to regenerate were affected by the dia betic state (Starzl et al. 1975a, b, c). 
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SPLANCHNIC DIVISION EXPERIMENTS 
Eventually, another kind of double fragment model provided much more 
decisive information about the nature and action of splanchnic hepatotrophic 
factors (Starzl et al. 1973). In these experiments, one portion of the liver was 
fed by the effluent of hormone-rich blood returning from the pancreas, duo-
denum, stomach and spleen. The opposite lobes were perfused via a graft 
with nutrition-rich blood returning from the intestine (Fig. 4A). 
The morphological results in 60-day experiments were dramatic. The hepatic 
lobules receiving pancreaticoduodenal venous effluent became large compared 
to those perfused with nutrient-rich intestinal blood. The individual hepatocytes 
on that side were strikingly bigger, had evidence of hyperplasia, and contained 
much glucogen compared with the cells on the other side. Other differences in 
chemical composition were also noted to which we shall return later. 
The probability that insulin was the major cause for the differences between 
PANCREATECTOMY 
Splanchnic division 
FIG. 4. Splanchnic division experiments in wnich the rignt liver lobes received venous return 
from the pancreaticogastroduodenosplenic region and the left liver lobes received venous 
blood from the intestines. A. Non-diabetic dogs. B. Alloxan-induced diabetic dogs. c. Dogs 
with total pancreatectomy. (From Starzl et al. 1975b, by permission of Surgery, Gynecology & 
Obstetrics.) 
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FIG. 5. The effect on hepatocyte size of alloxan-induced diabetes and the diabetes of total 
pancreatectomy in dogs with splanchnic division. The splanchnic division diverted pancrea-
ticogastroduodenosplenic blood to the right lobes (R), whereas the left lobes (L) received 
intestinal venous blood. 
the two sides was strengthened by additional 60-day experiments in which 
alloxan diabetes and pancreatectomy (Fig. 4B, c) were superimposed upon 
splanchnic division (Starzl et al. 1975a, b). In these dogs, pancreaticoduodeno-
gastrosplenic blood was directed to the right lobes and intestinal blood to 
the left lobes. In control non-diabetic dogs after splanchnic division, the liver 
cells in the hormone-enriched right lobes became hypertrophic as expected; 
the left lobes atrophied. These effects were cancelled about equally by alloxan 
diabetes or pancreatectomy (Fig. 5). In all such experiments, the nearly equal 
effect of alloxan poisoning and pancreatectomy tended to minimize any major 
role of glucagon as a hepatotrophic factor (Starzl et al. 1975b), contrary to an 
earlier hypothesis we had advanced (Starzl et al. 1973) that insulin and gluc-
agon would be synergistic. We emphasize again that these diabetic animals 
had to be treated with insulin which was delivered to both hepatic sides. 
The effect of insulin on cell proliferation was also convincingly demonstrated 
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TABLE I 
Numb.:r of labelled hepatocytes per 1000 hepatocytes in dogs 
Group Description No. dogs Right lobes 
(mean ±S.D.) 
I Normal 11 1.6±O.5 
2 Non-diabetic· 6 17.3±3.8 
3 Alloxan· 4 4.9±O.4 
4 Pancreatectomy" 5 5.1 ±I.O 
"Animals had splanchnic division. 
119 
Left lobes 
(mean ± S.D.) 
1.5±04 
4.0±I.O 
17.8 ±3.6 
17.5±3.9 
(Starzl et al. 1975b). In non-diabetic animals with splanchnic division, the 
right liver lobes receiving pancreatic blood had unequivocal autoradiographic 
evidence of hepatocyte hyperplasia relative to the left lobes, although both 
sides had greater cell renewal than normal. The right lobar dominance was 
eliminated and indeed was transferred to the left side by either alloxan or 
pancreatectomy diabetes in the insulin-treated animals (Table 1). 
Shifts of DNA synthesis were also brought about by diabetes (Starzl et al. 
1975b). In non-diabetic dogs after splanchnic division, the right lobes which 
were perfused with pancreatic blood had the dominant DNA synthesis. This 
dominance changed over to the left with the addition of either treated alloxan 
or pancreatectomy diabetes (Fig. 6). 
The effects of these various manipulations on lipid metabolism were also 
marked (Starzl et al. 1975a). In normal unaltered dogs, cholesterol synthesis 
was equal on both liver sides. After splanchnic division in non-diabetic animals, 
the liver portion being perfused with blood from the pancreas and upper 
splanchnic organs had much greater cholesterol synthesis than the other liver 
portion being perfused with venous return from the intestine. This dominance 
of cholesterol synthesis was eliminated and reversed, both by alloxan diabetes 
and total pancreatectomy, in insulin-treated dogs. Triglyceride synthesis 
followed the same pattern. 
Although the foregoing remarks are based on 60-day splanchnic division 
experiments, it should be added that most of the described changes have now 
been shown in this same model (and also after partial transposition) to be 
nearly complete within four days (Starzl et al. 1975c). 
The four-day experiments convincingly confirmed the role of insulin in con-
trolling both cell size and cell proliferation in the acute regeneration that foll-
owed 30 ~~ or 60% hepatic resections. The absence or paucity of insulin caused by 
alloxan diabetes or total pancreatectomy was associated with defective regen-
eration (Starzl et al. 1975c). A prominent role could not be identified for glu-
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FIG. 6. Deoxyribonucleic acid synthesis in the right (R) and left (L) liver lobes of normal 
dogs and of non-diabetic or diabetic dogs approximately two months afler splanchnic divi-
sion. The actual values for [CH3 - 3 Hjthymidine uptake were converted to percentages in which 
the side with the greater thymidine uptake was accorded 100 %. (From Starz! et al. 1975b. 
by permission of Surgery, Gynecology & Obstetrics.) . 
cagon in these four-day experiments any more than in the 60-day ones. How-
ever, the possible compensatory action of gut glucagon after pancreatectomy 
in the double liver fragment preparations of Figs. 2c and 4c made it impossible 
in these models to rule in or out a hepatotrophic action of glucagon. 
PORTAL INFUSION EXPERIMENTS 
We return full circle to the Eck fistula. If insulin was the most vital portal 
hepatotrophic factor, the reason for its unmasking by the double liver frag-
ment experiments became understandable. The well-known efficiency of in-
sulin's removal during a first pass through hepatic tissue made the insulin 
relatively unavailable for a second liver or liver fragment. At the same time 
the benefit after portal diversion from flow augmentation procedures such as 
Child's portacaval transposition was explained. If insulin and other hepato-
trophic substances were bypassed around a single liver, they would be returned 
to it in diluted form in direct relation to the total hepatic blood flow which 
these procedures increased. 
If the secrets of the Eck fistula were caused by deprivation of the liver of 
direct access to endogenous insulin, the experiment shown in Fig. 7 should 
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FIG. 7. Experiments in which Eck fistula is performed and postoperative infusions are made 
into the left portal vein. (From Starzl et 01. 1976, by permission of The Lancet.) 
have been a direct test of that hypothesis. Non-hypoglycaemic infusions of 
insulin and other substances were made for four days into the tied-off left 
portal vein after Eck fistula. The design of the experiment allowed an evalua-
tion of any direct protective effect on the left lobar hepatic tissues as well as a 
judgement of whether there was a spillover effect on the right lobes after 
recirculation. 
The results were unequivocal (Starzl et al. 1975d, 1976). Insulin greatly 
red uced the acute atrophy that otherwise halved the size of the cells (Table 2). 
and it preserved hepatocyte ultrastructure. In small doses, glucagon did not 
potentiate the action of insulin and, in large doses, it may have reduced the 
insulin benefit. Glucagon alone in either small or large doses had no effect 
under the conditions of this experimental model. 
The effect of insulin on hepatocyte proliferation was also striking (Table 3). 
After Eck fistula, the mitotic rate was increased to about three times normal, 
from 1.5 to 4.5-5 per 1000 cells. Insulin more than tripled this cell renewal, 
with no spillover to the contralateral lobes. Glucagon alone had no effect, nor 
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TABLE 3 
Cell division in the livers of 63 dogs (groups as in Table 2) 
No. of labelled hepatocytes 
No. of per lOOO hepatocytes P values· 
Group no. experiments (mean ±S.D.) (L4 versus R4) 
Left Right 
8 4.9± 1.0 4.7±0.9 N.S. 
6 4.6±0.8 4.7±0.9 N.S. 
9 \3.0±3.9 4.6±0.9 < 0.001 
4 15.6±2.0 5.3±1.0 < 0.001 
8 14.4± 1.1 4.8±1.0 < 0.001 
8 4.9±0.9 4.3±0.6 < 0.05 
6 4.2± 1.5 4.3±1.1 N.S. 
7 11.8 ± 1.2 4.5±0.8 < 0.001 
7 14.8 ± 1.0 4.5±0.9 < 0.001 
'Comparisons were by Student's t test. 
In unaltered or sham-operated dogs the left and right lobar values respectively were 1.6±0.4 
and 1.6±0.5. The increase caused by Eck fistula is significant (P < 0.001). 
did it potentiate the action of insulin. 
Thus, it has been established that relative 'hepatic insulinopenia' is the most 
important element in the liver injury of Eck fistula. It would be regrettable 
now if the very clarity with which insulin has emerged as a principal hepato-
trophic substance were to obscure the search for contributory factors. The 
observation that the insulin protection in our infusion experiments was not 
complete may be a reflection of missing ancillary substances. 
PORTAL INFUSION IN EVISCERATED DOGS 
The problem has been to find appropriate in vivo models with which to 
examine factors other than insulin. A final preparation which we are currently 
using in dogs should permit more quantitative studies of 'minor' hepatotrophic 
hormones than had previously been possible. In essence, the splanchnic or-
gans are removed, except the liver (Fig. 8). In some experiments, the colon 
is retained and anastomosed to the oesophagus, leaving a source of an estimated 
20 % of gut glucagon. In other experiments, the colon and rectum are also 
excised. The base of the mesentery with an arterial inflow plus the portal vein, 
which thus has some residual flow returning from the mesentery, are retained 
(Fig. 8). 
Endogenous insulin and pancreatic glucagon levels postoperatively reach 
low levels in 48 hours. The portal infusion of exogenous hormones in this model 
· ' 
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V 
Esophagus 
Bile 
catheter 
FIG. 8. Evisceration procedure under investigation. 
is under way, including insulin, glucagon, secretin, cholecystokinin, vasoactive 
intestinal polypeptide, somatostatin, growth hormone, and epidermal growth 
factor. 
BIOCHEMICAL QUESTIONS 
Although we have learned a lot about the so-called hepatotrophic influences 
of insulin and other hormones, the cellular mechanics of these effects remain 
obscure. In this final section, we shall discuss one of bur earlier observations 
(Starzl et af. 1973) which illustrated the interdependence of hormone factors, 
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FIG. 9. Changes in peripheral and portal venous insulin and hepatic cyclic AMP, occurring 
in a normal dog infused with tolbutamide. (From Starzl et aJ. 1973, by permission of Surgery, 
Gynecology & Obstetrics.) 
as also will be developed in several other papers in this symposium. As a 
first step, the insulin response to 40 mg/kg tolbutamide was shown to be sub-
stantially greater in the portal than in the systemic venous blood of normal 
dogs at the same time as little change occurred in the concentration of hepatic 
cyclic AMP (Fig. 9). Then, in dogs with the double liver fragment prepara-
tions shown in Figs. 2A and 4A, the same tolbutamide conditioning was car-
ried out 25 minutes before systemic venous infusions of 1.4 J1.g/kg of glucagon 
given over eight minutes. 
There were modest increases of cyclic AMP in the liver tissue that was per-
fused with insulin-rich total splanchnic return (Fig. to) or splanchnic return 
from the pancreas and other upper abdominal organs. In contrast, there were 
spectacular increases in cyclic AMP in the liver tissue that was not 'protected' 
by endogenous insulin (Fig. 10). The results indicated in a dynamic test system 
not only the importance of insulin per se but also the role of insulin in modi-
fying the response to glucagon. By extrapolation from the work of Bataille 
et al. (1974) in Freychet's laboratory, some insulin modification is a possibility 
for gut glucagon and vasoactive intestinal polypeptide (VIP), which stimulate 
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blood had a restraining influence on the cyclic AMP response to the exogenous glucagon 
whereas the response in the other lobes was uninhibited. (From Starzl et al. 1973, by permis' 
sion of Surgery, Gynecology & Obstetrics.) 
adenyl ate cyclase and glycogenolytic activity. 
Although the foregoing principle of hormone interaction seems established 
the final picture, as shown by more recent studies of the evisceration prepara-
tions (Fig. 8, p. 124), is not going to be such a simple one as having anabolic 
hormones depress adenyl ate cyclase and catabolic hormones cause elevations. 
If all the non-hepatic splanchnic organs are removed, the adenylate cyclase 
activity in these livers is decreased about 50 % under basal conditions as well 
as with either glucagon or sodium fluoride stimulation (Fig. 11). The admini-
stration of purified insulin into the portal vein of such animals restores adenyl-
ate cyclase to normal (Fig. 11) arid heightens the DNA synthesis. These ex-
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FIG. 11. Adenylate cyclase activity in dog liver homogenate, measured by the method of 
Salomon et al. (1974). 
periments have confirmed the power of insulin in the absence of all other 
splanchnic factors, and they have shown that insulin controls adenylate cyclase 
in the appropriate circumstances. 
Another example of how conditions may be changed by an experimental 
modification is shown in Table 4. These normal dogs had been subjected to 
65 % hepatectomy two days before the experiment and the liver remnants 
showed a seven-fold increase in DNA synthesis.' The basal adenylate cyclase 
activity was normal during this burst of regeneration and so was the total 
adenylate cyclase activity after sodium fluoride stimulation. However, the 
responsiveness to different concentrations of glucagon was greatly reduced. 
This was a direct demonstration that the cell membrane receptors for glucagon 
were less sensitive during regeneration, as Leffert et al. (1976) claimed earlier. 
Parenthetically, the observations tend to minimize the importance of glucagon 
in regeneration, but the evidence is not conclusive. 
TABLE 4 
Adenylate cyclase activity in dog liver during regeneration (48 hours after 65 % hepatectomy)" 
Basal Glucagon (moles) Sodium 
activity 10- 9 10- 8 10- 7 10- 6 10- 5 fiuoride 
stimulation 
18 normal dogs 18.6i::6 4O:!:12 59=13 77=17 95=12 97±24 126±39 
Regeneration: 
Dog I t:! 15.7 23.1 30.1 33.5 32.9 175.1 
Dog :2 19 20 35 45.1 76.4 80.5 140.6 
"Values are nmoles of cyclic AMP/mg protein homogenate per 15 min at 37 'c 
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Discussion 
McIntyre: Have you repeated the experiment of Rous & Larimore (1920) 
in which they damaged (by bile duct ligation) the side of the liver that should 
have hypertrophied? If so, did you prevent hypertrophy and did you stop or 
reduce atrophy of the side deprived of portal blood flow? 
Starzl: If you damage the liver by any means, including bile duct ligation, 
you can reduce, if not prevent, hypertrophy. We have not done exactly the 
same experiment as Rous & Larimore, but we did something analogous with 
an auxiliary liver model. If one of two co-existing livers was given a portal 
splanchnic inflow, its expected advantage was partly eliminated if its duct 
system was ligated (Faris et al. 1966). Thus, I think that Rous & Larimore's 
conclusions were valid. 
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Jt'einbren: Rous & Larimore claimed that if you tied the bile duct to the ad-
vantaged side, you prevented both hypertrophy and atrophy, so they concluded 
that atrophy depended on hypertrophy. It is amazing that this is a riddle that 
has never been solved, because whenever you try to get differential function or 
differential flow into two sides of the liver, the disadvantaged side always 
atrophies in the rat, and when it atrophies the other side enlarges. That is the 
stumbling block in that experiment. It is difficult to say which comes first, 
which is why it is still a riddle. But we have confirmed their results in the rat. 
Ligating the bile duct has two effects. You create an increased intravisceral 
tension in the affected lobe, so the portal blood does not get into the lobe so 
easily. Also the bile ducts proliferate on that side. There is a relationship 
between the bile duct proliferation and atrophy of liver cells; the bile duct 
proliferates better if the liver cells atrophy. 
Leffert: Dr Francavilla, have you any conclusions about the functional 
effect of the loss of adenylate cyclase? It might be premature to conclude that 
because glucagon activation is reduced, this indicates that the hormone's 
effects actually are being diminished. 
Francavilla: Our data in vitro show that during the early stage of regeneration 
there are important changes in the responsiveness to glucagon of cell membrane 
adenylate cyclase. At 48 hours, physiological concentrations of glucagon 
(l0-9 -10 - 8M) are unable to stimulate in vitro adenylate cyclase activity. 
This finding, taken together with the specific hormonal receptor changes 
associated with liver regeneration (Leffert et al. 1975), supports the idea that 
glucagon is not important during all stages of liver regeneration, although it 
may be important at the beginning. 
Leffert: These changes are rather late when one looks at regeneration; one 
doesn't see loss of responsiveness to the hormone until after 12 hours, as meas-
ured with isolated liver plasma membranes (H.L. Leffert & B. Rubalcava, 
in preparation). By then, many biochemical changes have occurred. Also, if 
glucagon is not important in liver regeneration,why is it obligatory in Nancy 
Bucher's regeneration model in which total pancreatectomy is accomplished 
(Bucher & Swaffield 1975)? 
Bucher: It may be difficult to evaluate the importance of glucagon properly 
in work with dogs because of the abundance in this species of gastrointestinal 
glucagon, which of course is not eliminated by pancreatectomy (Unger & 
Orci 1976). 
Leffert: Dr Starzl, could you comment on the elevated basal [3H]thymidine 
labelling index (4.5, as against a control of 1.5)? Might this be due to chron-
ically elevated blood glucagon levels? Secondly, did you correlate the size of 
the hepatocytes that were labelled with [3H]thymidine with onset times? You 
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suggested that this was direct evidence for atrophy not being a causal factor 
in the increase in labelling. 
Starzl: What I said was that this work (Starzl et al. 1976), studies by Wein-
bren et af. (1975), investigations by Rubin et al. (1965) and work we have re-
ported with the split liver preparations (Starzl et al. 1975a, b, c) all indicate 
that atrophy and hypoplasia don't necessarily go together, nor do hyper-
trophy and hyperplasia. 
Conceivably, the dissociation could be contributed to by hyperglucagon-
aemia, but we have been remarkably unsuccessful in demonstrating much effect 
of glucagon on hepatocyte proliferation. In speculating on the increased celI 
renewal after Eck fistula, Rubin et al. (1965) suggested that the damage or 
atrophy caused by the Eck fistula is, in itself, a stimulus for renewal. 
Of course, it is not known what sets the level of basal cell renewal in such 
situations, but there are paradoxes such as that described by Younger et al. 
(1966) in diabetic rats. In the livers of these insulinoprival animals there were 
more cells than normal and higher basal cell renewal. Yet when insulin was 
given there was a further burst of mitoses. 
Alberti: Dr Porter, did you look at glycogen in the cells exposed to insulin 
plus high levels of glucagon? (These were the disparate ones.) Could loss of 
glycogen in response to a high glucagon concentration have made any difference 
to cell size? 
Porter: It probably was a factor, but not a major factor. 
Alberti: Secondly, I wasn't clear whether adenylate cyclase still responded 
to other hormones and was just resistant to glucagon, or was resistant to many 
different hormones. Did you try noradrenaline? 
Francavilla: No, we only tried glucagon. 
Steiner: Several other studies have suggested that insulin either lowers or 
doesn't affect hepatic adenylate cyclase activity in experimental animals (Pil-
kis & Park 1974), and it is thus surprising that you find it increased, or protect-
ed, by insulin in this situation. Most commercial insulin preparations are con-
taminated with small amounts of glucagon and possibly there was enough 
glucagon in the insulin to protect or maintain adenylate cyclase activity. 
Francavilla: We are using pure insulin (Lilly) which contains only 0.002 ~~ 
glucagon. 
Steiner: We are talking about the amount of glucagon that might be required 
to maintain an activity of an enzyme, however. 
Blumgart: The estimates of hyperplasia are based on thymidine labelling. 
What is the curve of labelling after hepatectomy in the dog? Is it characterized 
sufficiently, and at what time did you make your measurements after the 
split operations? 
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Starzl: After hepatectomy, the greatest burst of labelling activity in the dog 
is at 2-3 days. The observations I mentioned after hepatic resection were made 
after 48 hours. As Dr Bucher said, the peak mitotic activity is later in the dog 
than in the rat. 
The observations in the divided liver preparations were after four days or 
after two months. Studies in dogs with portacaval shunt with or without insulin 
infusion were after four days. 
Weinbren: Your liver cells after alloxan seem to be the same size as normal, 
but I thought you stated that after alloxan the liver cells atrophy just as if you 
had deviated the portal flow away? 
Porter: They are about normal size after alloxan, but they contain a lot of 
fat. 
Alberti: I am becoming increasingly confused about species differences. Some 
people are using beef insulin in dogs or in rats, and there are species differences 
in insulin structure. We are also using very high glucagon concentrations. I 
should like to know whether glucagon concentrations have been measured in 
the blood flow to different parts of the liver, particularly because of the gluc-
agon that may be coming from the gut in dogs; this is a very murky area. 
Has anyone used insulin from the species which is being investigated, like rat 
insulin or dog insulin, in vivo or in culture? 
Leffert: Dr Freychet showed that there is not much difference in functional 
response if you change the species of hormone, except for guinea-pig (Freychet 
et al. 1971). 
Alberti: In the rat you are using massive amounts. We do the same: we treat 
our rats with 2u/day of ox insulin per kg body weight. 
Steiner: Actually, when we treated chronically diabetic rats with insulin 
subcutaneously over a long period in order to determine the correct dose to 
restore them to a normal growth rate, it turned out to be somewhere between 
2 and 4 units of PZI per day (Steiner et al. 1961). Thus this is not such a large 
dose. In studies with T. L. Blundell and S. P. Wood (in preparation, 1977), 
we have noted that both rat insulins bind less well than other insulins to fat 
cells, at about the level of 40-50 % as compared with porcine insulin, and they 
also have a correspondingly lower biological activity in various in vitro test 
systems. Thus both rat insulins are less active in rats than porcine insulin. 
However, there are no apparent differences in the nature of their biological 
effects. 
Freychet: 1 agree with that. In rat liver membranes, insulins from various 
animal species are effective in competing with the binding of 12sI-Jabelled 
porcine insulin, the only known exception (in mammals) being guinea-pig 
insulin. Like Dr Steiner, we too have observed that rat insulins I and II are 
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less potent than most other mammalian insulins in competing with the binding 
of 125 I-labelled insulin to rat liver membranes (P. Freychet, S. P. Wood & 
T. L. Blundell, unpublished work 1974). 
Star::!: The dose we infused to get the effects we described after Eck fistula 
was about 0.5 u/kg per day, delivered intraportally, either pig or beef insulin. 
At this dose, the dogs did not become hypoglycaemic. Dr Porter noticed, in 
some accidents when the pumps weren't working properly, that we got most of 
the protective effect with 1/5 or 1/4 of that amount. Thus, protection against 
hepatic injury was possible with very much smaller doses than the ones we 
usually used. 
Bloom: Dr Starzl, when systemic blood is going to one lobe (right) and portal 
blood to the other (left), there is some insulin entering the systemically supplied 
lobe, yet it atrophies. Obviously this is a very dose-dependent event. Have 
you given insulin into the systemic circulation, which would then go back to 
the right lobe, thus switching off the insulin going from the pancreas to the left 
lobe? Exactly how much insulin does one have to give to restore the balance? 
Star=!: We haven't done this, but it would be a good experiment. 
Leffert: We have found that under the appropriate in vitro conditions, DNA 
synthesis initiation can be stimulated with a few nanograms per millilitre of in-
sulin (Fig. 1, p. 62; Leffert 1974a; Koch et aj. 1976; Leffert & Koch 1977). 
These concentrations are within the physiological range. Richman et al. (1976) 
also reported stimulation of DNA synthesis by nanogram concentrations of 
insulin (together with epidermal growth factor and glucagon). They included 
serum in their medium; we didn't. Proliferation does not occur in their system; 
it does in ours. 
Blumgart: We measured flow in a split splanchnic preparation in five dogs. 
We found essentially the same weight changes as Dr Starzl did. We measured 
flow by a krypton clearance technique in both halves of the preparation. There 
was no significant difference in liver blood flow preoperatively, immediately post-
operatively or 60 days later between the right and left sides. Thus, in this dog pre-
paration, the changes Dr Starzl has shown were not related to flow. However, in 
Dr Starzl's experiments the side that atrophied was always the side that had the vein 
graft carrying blood from the gut. Nevertheless, our results do not exclude the pos-
sibility that flow is important in other situations. For instance, in one of your ex-
periments insulin was infused directly into one lobe and then glucagon was infused 
into a lobe with no portal flow. This had no effect, but with a completely ligated 
portal vein you would not expect to see an effect of glucagon in relation to flow. 
Starz!: How does glucagon increase flow, then, if it cannot affect the re-
maining arterial supply? 
Blumgart: I don't know whether the precise mechanism has been worked 
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out. We have started to work on this question. 
Bloom: Glucagon is used for coeliac axis angiography because it gives massive 
coeliac artery dilatation. 
Starzl: It shouldn't necessarily lose this effect, should it, just because it is 
infused into the tied-off central portal vein? 
Blumgart: I agree that glucagon might have an effect on arterial flow and 
cause some increase. I am suggesting that while we can support your results in 
the split splanchnic situation, it is not right to exclude blood flow as a possible 
factor in other experiments. 
Bloom: Glucagon might be useful to test in mice, with viral hepatitis for 
example, where it might keep blood flow going to areas that have become 
thrombosed and necrotic secondary to the infection. 
Smith-Laing: Dr Starzl, in the split liver preparations combined with pan-
createctomy or alloxan diabetes, splanchnic flow appeared to replace the effect 
of insulin on the liver. The amount of gut glucagon that might have been there 
would have been much less than in, say, Nancy Bucher's work. What is it in 
that insulin-free splanchnic flow that protects the liver? 
Starzl: I don't know; Steve Bloom may have to tell us that! There are lots 
of candidate substances. 
However, I do want to correct the impression I apparently left that the 
splanchnic venous blood was insulin-free in these diabetic dogs. Most of the 
animals were being treated with subcutaneous insulin, so that dilute exogenous 
insulin went to both sides. Thus, the advantage enjoyed by the liver tissue 
receiving splanchnic inflow was due to other factors but added to small 
amounts of insulin. The important conclusion from this kind of experiment 
is that insulin is not the only hepatotrophic factor. 
Smith-Laing: It looks like an area to focus on, because at no other time have 
you shown a synergistic effect with insulin using other peptides which you 
might expect to find in splanchnic blood. But all the same there appears to 
be something in splanchnic flow that protects the liver. 
Starzl: I think that is exactly right. The obvious candidate substances are 
other hormones, or perhaps nutrients absorbed from the intestine. 
Smith-Laing: Could there be a 'pecking order' in responsiveness? If you 
don't have insulin, can the liver respond to something else to which it wouldn't 
normally respond in the presence of insulin? 
Starz/: We think there probably is a pecking order and that insulin may deter-
mine that order. That would be the implication of some of Dr Francavilla's 
findings, such as the protective influence of insulin on adenylate cyclase activity, 
as was discussed earlier (p. 127). 
Leffert: What is the likelihood that splanchnic blood supplies prostaglandins 
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from adipose stores in the splanchnic bed? We found, using the in vitro fetal 
liver system, that nanogram levels of POE 1 stimulate DNA synthesis (Leffert 
et al. 1976). Dr L. Levine measured 'POEt' for us in portal blood and found 
concentrations to be elevated after 70 % hepatectomy about three-to four-fold. 
Steiner: I shall be describing some work later (pp. 229-236) which suggests 
that there are factors or processes that 'down' regulate liver mass as well as 
'up' regulate it. In Dr Starz!'s experiments it may be that the atrophied side 
of the liver is being suppressed by the normal side. Then when you take away 
the stimulus that maintains the relative hypertrophy on the normal side, you 
create a new balance which now tends to bring up the atrophic side while the 
hypertrophic side slides back. The question is whether factors arriving in the 
intestinal blood are the signals for this, or whether there are more intrinsic 
mechanisms that sense liver size in addition. 
Starz!: In that connection, I would like to point out a fundamental diff-
erence between the two split liver preparations which we used. In one (partial 
transposition), all the splanchnic blood goes to one liver side and all the vena 
caval flow goes to the other. With the second model (splanchnic division), 
insulin-rich blood goes to one side and nutrient-rich intestinal blood to the 
other. 
After partial transposition, the presumably deficient qualities of systemic 
blood are devastating on the side receiving it, in that atrophy and other 
changes occur with great rapidity and completeness. Several years ago we 
suggested (Starzl et al. 1973) that there might also be 'down regulation' by 
something in the systemic venous blood (as opposed to deficiency of sub-
stances) to account for the accelerated involution. Because the transposition 
was done above the adrenal glands, an obvious possibility was that adrenaline 
had such a 'down regulating' influence. 
Popper: I would like to raise the question of different effects on different 
hepatic cells, I believe your slides showed less reticulum framework in the 
non-atrophic area. This could be explained by an approximation of the ret-
iculum fibres as a result of atrophy of the cells. Also, the portal tracts looked 
darker on the atrophic side, which suggests new formation of fibres stimulated 
by deprivation of hepatotrophic substances. This would raise the interesting 
possibility that active fibrogenesis is associated with atrophic hepatocytes. 
Porter: I am sure you are right. In the silver preparations there is an increase 
in silver-staining fibres round the portal tract on the atrophic side. 
Bloom: Clinically, one sees patients with livers which are large because they 
have acromegaly. As far as I know the livers really are enlarged. One wonders 
what happens when growth hormone is added to isolated liver cell preparations. 
If it is not particularly potent there and doesn't act directly on hepatocytes, is 
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this an indication that the in vitro preparations may not allow us to detect cer-
tain types of growth factor? 
Mcintyre: John Jenkins (personal communication 1977) and Mike Davis 
of St George's Hospital have been transplanting pituitary tumours in rats. 
The livers of the recipients became enormous with intense mitotic activity. The 
tumours secreted prolactin as well as growth hormone and the insulin levels 
in the recipient rats were 3-4 times normal. Apparently the livers were 3-4 
times larger than normal. 
Bloom:' Prolactinaemia does not produce this effect in man. The high levels 
of insulin might be due to diabetes-for example, insulin resistance. If this 
were the hepatotrophic factor, I think you would expect to find big livers in 
obese people or those with Cushing's syndrome. Thus one might suspect that 
the observed effect was due to growth hormone alone. 
Freychet: Did these transplantable tumours also produce ACTH? Some 
pituitary tumours in the rat secrete ACTH, prolactin and growth hormone. 
Mclntyre: No, and steroid levels in tbe tumour-bearing rats were normal. 
Leffert: We reported (Leffert 1974a) that an NIH Study Section preparation 
of somatotropin enhanced the action of insulin and glucocorticoid in stimul-
ating DNA synthesis initiation in the fetal liver culture system. We have since 
shown that this enhancement was due to a contaminant of the preparation 
(Leffert & Koch 1977). We were assured that it was pure; but when we ob-
tained pure growth hormone (from Dr W. Vale) it was inactive in our assay. 
As far as I know, no one has found a convincing direct effect of growth hor-
mone in stimulating DNA synthesis in animal cells in vitro. 
Bloom: You can see it in vivo but not in vitro, perhaps? 
Popper: In leukaemia the liver is enlarged even if leukaemic cells do not ac-
cumulate in the liver, for instance after anti leukaemic therapy. The enlarge-
ment is explained by both hyperplasia and hypertrophy of the hepatocytes 
(Wolf & Klemperer 1955). This suggests the presence of growth factors in 
leukaemia. As a matter of fact, an enlarged liver with normal hepatocytes 
and without inflammatory cells suggests leukaemia. 
Leffert: Many tumours produce what many people think are hepato-
mitogenic peptides (Morgan & Cameron 1973; Ibsen 1977). 
Bloom: The results of Jenkins and Davis are in line with what happens 
clinically in man. Acromegalic patients have large livers which are not infil-
trated or in any other way diseased. 
Alberti: Did they measure somatomedins? 
McIntyre: I don't know. Has anyone tested somatomedins? 
Leffert: The C form of somatomedin promoted DNA synthesis initiation in 
the fetal liver system and it was additive with insulin (Leffert 1974a). We tested 
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